News Releases

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel Go

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel Go

Email Alerts

Year All Years 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Keywords Go

Advanced Search

Keywords

  Search Headlines Only

From

To

Asset Types

 Photos  Video  Audio  Documents  Events  Standard

 Basic Search

• May 1, 2018

  Insmed to Present at the Deutsche Bank 43rd Annual Health Care Conference
• Apr 25, 2018

  Insmed to Host First Quarter 2018 Financial Results Conference Call on Wednesday, May 2, 2018
• Mar 29, 2018

  Insmed Submits New Drug Application to FDA for ALIS in NTM Lung Disease Caused by MAC

  ALIS previously designated as an orphan drug, breakthrough therapy and Qualified Infectious Disease Product (QIDP)
• Mar 7, 2018

  Insmed to Present at the Cowen and Company 38th Annual Health Care Conference
• Feb 23, 2018

  Insmed Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

  On track to file NDA before the end of March and anticipate a priority review

Show 5102550100 per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

Sign Up

View the latest Insmed Investor Presentation

Download